Analyst Ratings for Sagent Pharmaceuticals (SGNT) [Buys]
SGNT Rating Summary
SGNT Price Target Summary
- Highest: $27.00 (Capstone Investments)
- Lowest: $16.00 (RBC Capital)
- Average: $21.56
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.56 (+31%)
Avg. $ Target:
$21.56 (+31%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/15/2013 | Piper Jaffray | Upgrade | Overweight (Neutral) |
22.00 (15.00) |
16.36 | 16.45 | 0.55% | Details |
| 6/7/2012 | Needham & Company » Updated 9/10/2012 |
Upgrade | Buy (Hold) |
20.00 (N/A) |
18.18 | 16.45 | -9.52% | Details |
| 4/17/2012 | Auriga | New Coverage | Buy (N/A) |
22.00 (N/A) |
17.36 | 16.45 | -5.24% | Details |
| 1/4/2012 | Capstone Investments | New Coverage | Buy (N/A) |
27.00 (N/A) |
21.50 | 16.45 | -23.49% | Details |
| 11/29/2011 | Collins Stewart | New Coverage | Buy (N/A) |
25.00 (N/A) |
21.12 | 16.45 | -22.11% | Details |
| 6/3/2011 | Jefferies » Updated 5/7/2013 |
New Coverage | Buy (N/A) |
21.00 (20.00) |
25.43 | 16.45 | -35.31% | Details |
